David G. Beer

92.1k citations

241 papers · 16.9k indexed · 4 hit papers · h-index 64

Impact in

Cancer Research top 0.1%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
- Cancer Genomics and Diagnostics
Molecular Biology top 0.2%
- RNA modifications and cancer
- Circular RNAs in diseases
- RNA Research and Splicing

Papers in

Cancer Research 71
- Cancer-related molecular mechanisms research 28
- Cancer Genomics and Diagnostics 17
Oncology 69
- Cancer-related Molecular Pathways 22

Co-authors: Guoan Chen Mark B. Orringer Thomas J. Giordano Samir Hanash Dafydd G. Thomas David E. Misek Mark D. Iannettoni Jeremy M. G. Taylor
Journals: Clinical Cancer Research (15 papers)Cancer Research (13 papers)Molecular Carcinogenesis (12 papers)Neoplasia (9 papers)Journal of Thoracic Oncology (9 papers)
Partner nations: United States China Japan

In The Last Decade

David G. Beer

238 papers receiving 16.6k citations

Hit Papers

align trajectories log scale

The landscape of long noncoding RNAs in the human transcriptome 2015 · 2.1k citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2015 Nature Genetics
2011 Proceedings of the American Thoracic Society
2002 Nature Medicine
2002 Molecular & Cellular Proteomics

Peers

Countries citing papers authored by David G. Beer

Since Specialization

Citations

This map shows the geographic impact of David G. Beer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David G. Beer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David G. Beer more than expected).

Fields of papers citing papers by David G. Beer

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David G. Beer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David G. Beer. The network helps show where David G. Beer may publish in the future.

Co-authors

The 25 scholars most cited alongside David G. Beer, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with David G. Beer Line = papers co-authored together David G. Beer links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	GRAIL1 Stabilizes Misfolded Mutant p53 through a Ubiquitin Ligase-Independent, Chaperone Regulatory Function Molecular Cancer Research ·Paramita Ray, Sangeeta Jaiswal, Daysha Ferrer-Torres, G. Wielgosiński, Derek J. Nancarrow, Ashok D. Rangari, J L Suarez, M D Whitaker, 王念奈, Dafydd G. Thomas, Jason R. Spence, Matthias C. Truttmann, Kiran H. Lagisetty, Theodore S. Lawrence, Thomas D. Wang, David G. Beer, Dipankar Ray	2024	0
2	Landscape summary: Online targeting: What is online targeting, what impact does it have, and how can we maximise benefits and minimise harms? ORCA Online Research @Cardiff (Cardiff University) ·David G. Beer, Joanna Redden, Ben Williamson, 多喜子雨宮	2019	1
3	Silencing of Long Noncoding RNA MIR22HG Triggers Cell Survival/Death Signaling via Oncogenes YBX1, MET, and p21 in Lung Cancer Cancer Research ·Wenmei Su, Ruth Levinson, Xiuyuan Chen, Xia Yang, Rui Mao, Chunfang Guo, Zhuwen Wang, Dafydd G. Thomas, Jules Lin, Rishindra M. Reddy, Mark B. Orringer, Andrew C. Chang, Zhixiong Yang, David G. Beer, Guoan Chen	2018	119
4	Poor Prognosis Indicated by Venous Circulating Tumor Cell Clusters in Early-Stage Lung Cancers Cancer Research ·Vasudha Murlidhar, Rishindra M. Reddy, Shamileh Fouladdel, Lili Zhao, Heung-Seob, Svetlana Grabauskiene, Zhuo Zhang, Jules Lin, Andrew C. Chang, Philip W. Carrott, William R. Lynch, Mark B. Orringer, Chandan Kumar‐Sinha, Nallasivam Palanisamy, David G. Beer, Max S. Wicha, Nithya Ramnath, Ebrahim Azizi, Sunitha Nagrath	2017	139
5	A MicroRNA Cluster at 14q32 Drives Aggressive Lung Adenocarcinoma Clinical Cancer Research ·Ernest Nadal, Jinjie Zhong, Jules Lin, Rishindra M. Reddy, Nithya Ramnath, Mark B. Orringer, Andrew C. Chang, David G. Beer, Guoan Chen	2014	85
6	Epigenetic Inactivation of microRNA-34b/c Predicts Poor Disease-Free Survival in Early-Stage Lung Adenocarcinoma Clinical Cancer Research ·Ernest Nadal, Guoan Chen, Priputnevich T.V. Priputnevich, Lin Lin, Daysha Ferrer-Torres, Anna Truini, Zhuwen Wang, Jules Lin, Rishindra M. Reddy, Roger Llatjós, Ignacio Escobar, Juan Moya, Andrew C. Chang, Felipe Cardenal, Gabriel Capellá, David G. Beer	2013	53
7	Integrative Genomics Identified RFC3 As an Amplified Candidate Oncogene in Esophageal Adenocarcinoma Clinical Cancer Research ·William W. Lockwood, Kelsie L. Thu, Lin Lin, Larissa A. Pikor, Raj Chari, Wan L. Lam, David G. Beer	2012	37
8	Prognostic Immune Markers in Non–Small Cell Lung Cancer Clinical Cancer Research ·Kei Suzuki, Stefan S. Kachala, Kyuichi Kadota, Ronglai Shen, Qianxing Mo, David G. Beer, Valerie W. Rusch, William D. Travis, Prasad S. Adusumilli	2011	147
9	Stromal LRP1 in Lung Adenocarcinoma Predicts Clinical Outcome Clinical Cancer Research ·He Meng, Guoan Chen, Xiaojie Zhang, Zhuwen Wang, Dafydd G. Thomas, Thomas J. Giordano, David G. Beer, Michael M. Wang	2011	35
10	Decreased Selenium-Binding Protein 1 in Esophageal Adenocarcinoma Results from Posttranscriptional and Epigenetic Regulation and Affects Chemosensitivity Clinical Cancer Research ·Amy L. Silvers, Lin Lin, Adam J. Bass, Guoan Chen, Zhuwen Wang, Dafydd G. Thomas, Jules Lin, Thomas J. Giordano, Mark B. Orringer, David G. Beer, Andrew C. Chang	2010	61
11	CYP24A1 Is an Independent Prognostic Marker of Survival in Patients with Lung Adenocarcinoma Clinical Cancer Research ·Guoan Chen, So Hee Kim, Amanda N. King, Lili Zhao, Robert U. Simpson, Paul J. Christensen, Zhuwen Wang, Dafydd G. Thomas, Thomas J. Giordano, Lin Lin, Dean E. Brenner, David G. Beer, Nithya Ramnath	2010	85
12	The Vitamin D/CYP24A1 Story in Cancer Anti-Cancer Agents in Medicinal Chemistry ·Amanda N. King, David G. Beer, Paul J. Christensen, Robert U. Simpson, Nithya Ramnath	2010	51
13	MicroRNA Classifiers for Predicting Prognosis of Squamous Cell Lung Cancer Cancer Research ·Mitch Raponi, Lesley Dossey, Tim Jatkoe, Xiaoying Wu, Guoan Chen, Hongtao Fan, David G. Beer	2009	333
14	An Embryonic Stem Cell–Like Signature Identifies Poorly Differentiated Lung Adenocarcinoma but not Squamous Cell Carcinoma Clinical Cancer Research ·Khaled A. Hassan, Guoan Chen, Gregory P. Kalemkerian, Max S. Wicha, David G. Beer	2009	51
15	Confirmation of Gene Expression–Based Prediction of Survival in Non–Small Cell Lung Cancer Clinical Cancer Research ·Nancy Lan Guo, Ying-Wooi Wan, Kürşad Tosun, Hong Lin, Sandra Díez de la Varga, Daniel C. Flynn, Scot C. Remick, Val Vallyathan, Afshin Dowlati, Xianglin Shi, Vincent Castranova, David G. Beer, Yong Qian	2008	81
16	Dual Tyrosine Kinase Inhibitor for Focal Adhesion Kinase and Insulin-like Growth Factor-I Receptor Exhibits Anticancer Effect in Esophageal Adenocarcinoma In vitro and In vivo Clinical Cancer Research ·Nobuyuki Watanabe, Munenori Takaoka, Kazufumi Sakurama, Yasuko Tomono, Shinji Hatakeyama, Osamu Ohmori, Takayuki Motoki, Yasuhiro Shirakawa, Tomoki Yamatsuji, Minoru Haisa, Junji Matsuoka, David G. Beer, Hitoshi Nagatsuka, Noriaki Tanaka, Yoshio Naomoto	2008	46
17	Autoantibody Profiles Reveal Ubiquilin 1 as a Humoral Immune Response Target in Lung Adenocarcinoma Cancer Research ·Guoan Chen, Xiaoju Wang, Jianjun Yu, Sooryanarayana Varambally, Jindan Yu, Dafydd G. Thomas, Mu-Yen Lin, Prakash Vishnu, Zhuwen Wang, Rui Wang, E D Putra, Debashis Ghosh, Thomas J. Giordano, Donald Giacherio, Andrew C. Chang, Mark B. Orringer, Talal El‐Hefnawy, William L. Bigbee, David G. Beer, Arul M. Chinnaiyan	2007	73
18	Hypermethylation of Tachykinin-1 Is a Potential Biomarker in Human Esophageal Cancer Clinical Cancer Research ·Zhe Jin, Alexandru Olaru, Jian Yang, Fumiaki Sato, Yulan Cheng, Takatsugu Kan, Yuriko Mori, Carmit Mantzur, Bogdan C. Paun, James P. Hamilton, Tetsuo Ito, Suna Wang, Stefan David, Rachana Agarwal, David G. Beer, John Abraham, Stephen J. Meltzer	2007	67
19	Gene Expression Signatures for Predicting Prognosis of Squamous Cell and Adenocarcinomas of the Lung Cancer Research ·Mitch Raponi, Yi Zhang, Jack X. Yu, Guoan Chen, Grace Lee, Jeremy M. G. Taylor, James W. MacDonald, Dafydd G. Thomas, Christopher A. Moskaluk, Yixin Wang, David G. Beer	2006	319
20	The murine Fhit gene is highly similar to its human orthologue and maps to a common fragile site region. PubMed ·Thomas W. Glover, T. Wen, Javier Álvarez, Seyed Hamid Sadat Hosseini, A. Adam, JOHN M. HARPER, Cailin Moira Wilke, Herman A. Dierick, David G. Beer	1998	56

About David G. Beer

David G. Beer is a scholar working on Cancer Research, Oncology, Gastroenterology, Molecular Biology and Pulmonary and Respiratory Medicine, having authored 241 papers that have together received 16.9k indexed citations. Recurring topics across this work include RNA modifications and cancer (45 papers), Esophageal Cancer Research and Treatment (44 papers), Cancer-related molecular mechanisms research (28 papers), Cancer-related gene regulation (23 papers), Cancer-related Molecular Pathways (22 papers), Lung Cancer Treatments and Mutations (19 papers), Epigenetics and DNA Methylation (19 papers) and Cancer Genomics and Diagnostics (17 papers). The work is most often cited by research in Cancer Research (5.8k citations), Molecular Biology (10.8k citations), Oncology (3.7k citations), Pulmonary and Respiratory Medicine (3.7k citations) and Immunology (1.3k citations). David G. Beer has collaborated with scholars based in United States, China and Japan. Frequent co-authors include Guoan Chen, Mark B. Orringer, Thomas J. Giordano, Samir Hanash, Dafydd G. Thomas, David E. Misek, Mark D. Iannettoni, Jeremy M. G. Taylor, Tarek G. Gharib and Sharon L. R. Kardia. Their work appears in journals such as Clinical Cancer Research, Cancer Research, Molecular Carcinogenesis, Neoplasia and Journal of Thoracic Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact